Earnings Summary

Conmed Corp’s revenue jumped 3.98% since last year same period to $316.7Mn in the Q3 2024. On a quarterly growth basis, Conmed Corp has generated -4.25% fall in its revenue since last 3-months.

Conmed Corp’s net profit jumped 209.3% since last year same period to $48.98Mn in the Q3 2024. On a quarterly growth basis, Conmed Corp has generated 63.41% jump in its net profits since last 3-months.

Conmed Corp’s net profit margin jumped 197.46% since last year same period to 15.47% in the Q3 2024. On a quarterly growth basis, Conmed Corp has generated 70.66% jump in its net profit margins since last 3-months.

Conmed Corp’s price-to-earnings ratio after this Q3 2024 earnings stands at 16.99.

Conmed Corp’s earning per share (EPS) estimates for the current quarter stand at 0.99 - a 8.79% jump from last quarter’s estimates.

Conmed Corp’s earning per share (EPS) estimates for the current year stand at 0.99.

Conmed Corp’s earning per share (EPS) jumped 16.67% since last year same period to 1.05 in the Q3 2024. This indicates that the Conmed Corp has generated 16.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Conmed Corp’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Conmed Corp’s return on equity (ROE) stands at 0.15.

Conmed Corp declared 0.2 dividend per share during the earnings announcement for Q3 2024.